NANO-X IMAGING (NNOX)

Nasdaq Mercado cerrado

Nano-X Imaging Ltd is a medical imaging technology company that seeks to broaden access to diagnostic imaging and support earlier detection of disease. The company’s platform combines imaging hardware, cloud-based infrastructure, artificial intelligence tools, radiology services, and healthcare information technology, positioning it at the intersection of medical devices, software, and outsourced clinical services.

Its best-known hardware initiative is the Nanox.ARC, an imaging system designed as a more accessible alternative to conventional medical imaging equipment. The broader Nanox model is not limited to the scanner itself. The company also develops software intended to connect imaging sites, radiologists, and healthcare providers, while its AI tools are designed to assist with the analysis of medical images and help identify conditions that may require clinical follow-up.

Nano-X Imaging reports its activities through three main areas: the Nanox.ARC segment, the AI and software solutions segment, and the radiology services segment. The radiology services business is an important revenue contributor, reflecting the company’s role in supporting image interpretation and related workflow services for healthcare providers. This gives Nano-X exposure not only to future adoption of its own imaging hardware, but also to ongoing demand for outsourced radiology capacity.

For investors, NNOX is a healthcare technology stock tied to the long-term themes of preventive care, imaging accessibility, artificial intelligence in diagnostics, and cloud-enabled clinical workflows. Its investment case depends on regulatory progress, commercial deployment, adoption by healthcare systems, and the company’s ability to prove that its integrated platform can deliver reliable imaging, efficient interpretation, and economically attractive services at scale.

1.93 USD
1.92 USD
−0.14 (-6.76%)
Premercado

Última actualización

Capitalización
PER
Precio/FCF
Precio/Ventas
Valor de empresa
Sector de actividad
Industria
Dirección
GlobeNewswire Inc.

NNOX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Nano-X Imaging Ltd.

06 may 2026, 00:00 A. M.
GlobeNewswire Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX

28 abr 2026, 23:40 P. M.
GlobeNewswire Inc.

NNOX SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

28 abr 2026, 02:22 A. M.
GlobeNewswire Inc.

NNOX Investors Have Opportunity to Join Nano-X Imaging Ltd. Fraud Investigation with the Schall Law Firm

27 abr 2026, 04:30 A. M.
GlobeNewswire Inc.

NANO-X INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Nano-X Imaging Ltd. on Behalf of Nano-X Stockholders and Encourages Investors to Contact the Firm

23 abr 2026, 23:40 P. M.
GlobeNewswire Inc.

Nanox Announces $15 Million Registered Direct Offering of Common Stock

24 nov 2025, 05:26 A. M.
GlobeNewswire Inc.

Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging

18 sept 2025, 14:00 P. M.
GlobeNewswire Inc.

Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication

05 dic 2024, 11:55 A. M.
GlobeNewswire Inc.

Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography

25 jun 2024, 14:00 P. M.
Zacks Investment Research

Are Business Services Stocks Lagging NanoX Imaging (NNOX) This Year?

20 jun 2024, 15:40 P. M.
Zacks Investment Research

Down -19.76% in 4 Weeks, Here's Why NanoX Imaging (NNOX) Looks Ripe for a Turnaround

19 jun 2024, 15:35 P. M.
Zacks Investment Research

Bears are Losing Control Over NanoX Imaging (NNOX), Here's Why It's a 'Buy' Now

12 jun 2024, 15:55 P. M.
GlobeNewswire Inc.

Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform

05 jun 2024, 14:00 P. M.
GlobeNewswire Inc.

USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission

08 may 2024, 14:00 P. M.
GlobeNewswire Inc.

Nanox Files 2023 Annual Report on Form 20-F

22 abr 2024, 15:40 P. M.
GlobeNewswire Inc.

Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market

09 abr 2024, 14:40 P. M.
GlobeNewswire Inc.

Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024

18 mar 2024, 13:30 P. M.
GlobeNewswire Inc.

Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold

12 mar 2024, 13:45 P. M.
GlobeNewswire Inc.

Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases

29 feb 2024, 14:00 P. M.
Zacks Investment Research

All Eyes on Nvidia Earnings: Here's What to Expect

21 feb 2024, 16:43 P. M.

Cuenta de resultados

Partida 2025 Q4 2024 Q4 2023 Q4 2022 Q4 2021 Q4
Ingresos
Beneficio bruto
Resultado operativo
EBITDA operativo 0 0 0 0 0
Beneficio neto
BPA básico
BPA diluido

Balance

Partida 2025 Q4 2024 Q4 2023 Q4 2022 Q4 2021 Q4
Activos totales 162.17M 210M 218.65M 253.93M 363.17M
Pasivos totales 22.43M 20.88M 23.13M 37.25M 71.02M
Patrimonio neto 139.73M 189.12M 195.51M 216.68M 292.15M
Efectivo y equivalentes 49.15M 39.3M 56.38M 38.46M 66.65M
Activos corrientes 66.79M 78.68M 88.59M 82.46M 94.86M
Pasivos corrientes 16.89M 13.97M 15.52M 25.07M 52.75M

Flujo de caja

Partida 2025 Q4 2024 Q4 2023 Q4 2022 Q4 2021 Q4
Flujo de caja operativo
Flujo de caja de inversión
Flujo de caja de financiación
Variación de efectivo
Tipo Informe Fecha Enlace
edgar index SCHEDULE 13G/A — Nano-X Imaging Ltd. Ver informe
edgar index 6-K — Nano-X Imaging Ltd. Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
form 3 Form 3 — Yahav Attias Gali Ver informe
form 3 Form 3 — Yahav Attias Gali Ver informe
form 3 Form 3 — Yahav Attias Gali Ver informe
form 3 Form 3 — Yahav Attias Gali Ver informe
form 3 Form 3 — Yahav Attias Gali Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
form 3 Form 3 — Alroy Erez Ver informe
form 3 Form 3 — Alroy Erez Ver informe
form 3 Form 3 — Alroy Erez Ver informe
form 3 Form 3 — Alroy Erez Ver informe
form 3 Form 3 — saban sharon Ver informe
form 3 Form 3 — saban sharon Ver informe
edgar index CORRESP — Nano-X Imaging Ltd. Ver informe
edgar index F-3/A — Nano-X Imaging Ltd. Ver informe
edgar index 4 — Nano-X Imaging Ltd. Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
form 3 Form 3 — Ronen Nehama Ver informe
form 3 Form 3 — Ronen Nehama Ver informe
form 3 Form 3 — Ronen Nehama Ver informe
edgar index UPLOAD — Nano-X Imaging Ltd. Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
form 3 Form 3 — Kainan Noga Ver informe
form 3 Form 3 — Kainan Noga Ver informe
form 3 Form 3 — Kainan Noga Ver informe
form 3 Form 3 — Kainan Noga Ver informe
form 3 Form 3 — Kainan Noga Ver informe
form 3 Form 3 — Kainan Noga Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
edgar index 3 — Nano-X Imaging Ltd. Ver informe
form 3 Form 3 — Aharon Cohen Tamar Ver informe
form 3 Form 3 — Aharon Cohen Tamar Ver informe
form 3 Form 3 — Aharon Cohen Tamar Ver informe
form 3 Form 3 — Aharon Cohen Tamar Ver informe
form 3 Form 3 — Aharon Cohen Tamar Ver informe
form 3 Form 3 — Aharon Cohen Tamar Ver informe
form 3 Form 3 — Koren Ofir Ver informe
form 3 Form 3 — Koren Ofir Ver informe
form 3 Form 3 — Koren Ofir Ver informe
form 3 Form 3 — Koren Ofir Ver informe
form 3 Form 3 — Koren Ofir Ver informe
form 3 Form 3 — Koren Ofir Ver informe
form 3 Form 3 — Jackman Michael Ver informe
form 3 Form 3 — Jackman Michael Ver informe
form 3 Form 3 — Jackman Michael Ver informe
form 3 Form 3 — Gofman Feler Marina Ver informe
form 3 Form 3 — Gofman Feler Marina Ver informe
form 3 Form 3 — Gofman Feler Marina Ver informe
form 3 Form 3 — Gofman Feler Marina Ver informe
form 3 Form 3 — Gofman Feler Marina Ver informe
form 3 Form 3 — Dara James Ver informe
form 3 Form 3 — Dara James Ver informe
form 3 Form 3 — Dara James Ver informe
form 3 Form 3 — Dara James Ver informe
form 3 Form 3 — Dara James Ver informe
form 3 Form 3 — Meltzer Erez Ver informe
form 3 Form 3 — Meltzer Erez Ver informe
form 3 Form 3 — Meltzer Erez Ver informe
form 3 Form 3 — Meltzer Erez Ver informe
form 4 Form 4 — Daniel Ran Ver informe
edgar index F-3 — Nano-X Imaging Ltd. Ver informe
edgar index 6-K — Nano-X Imaging Ltd. Ver informe
edgar index 6-K — Nano-X Imaging Ltd. Ver informe
edgar index 6-K — Nano-X Imaging Ltd. Ver informe
edgar index 6-K — Nano-X Imaging Ltd. Ver informe
edgar index 424B5 — Nano-X Imaging Ltd. Ver informe
edgar index 6-K — Nano-X Imaging Ltd. Ver informe
edgar index 6-K — Nano-X Imaging Ltd. Ver informe